# Cumberland Pharmaceuticals Inc: Form 8-K, filed Jul 1, 2026

- Company: [Cumberland Pharmaceuticals Inc](/companies/cpix.md) (CIK 1087294)
- Form: 8-K
- Filed: 2026-07-01
- Accepted by EDGAR: Jul 1, 2026, 16:15 ET
- Period: 2026-06-29
- Accession: 0001104659-26-079871
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1087294/000110465926079871/tm2619330d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1087294/000110465926079871/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 1.02: Termination of a material agreement
- Item 2.01: Completion of an acquisition or disposition
- Item 5.02: Departure or appointment of officers or directors
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1087294/000110465926079871/tm2619330d1_8k.htm

Filed Jul 1, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-079871. Last ingested by Listed: Oct 26, 2026, 16:41 ET. No prices; not investment advice.